drugset / Trial / NCT00198198

Aripiprazole Treatment of Bipolar Depression

NCT00198198

Phase 4 Completed 10 enrolled Indiana University
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a study of addition of aripirazole to the treatment of bipolar depressed patients who are not better on the medications that they are currently receiving.

Timeline

Start
2005-08
Primary completion
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 20 mg

Indications